MDGL

Healthcare Biotechnology

Madrigal Pharmaceuticals, Inc.

$499.40

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

11.54B

Avg Volume

292,198

EPS

-$12.85

52W High

$615.00

52W Low

$393.61

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

51.89

P/B Ratio

22.02

P/S Ratio

8.99

EV/EBITDA

-34.40

EV/Revenue

8.60

Margins

Gross Margin 91.5%

Operating Margin (15.5%)

Net Margin (25.3%)

EBITDA Margin (25.0%)

Growth & Returns

Revenue Growth (YoY)

71.2%

Return on Equity

(53.3%)

Return on Assets

(17.8%)

Liquidity & Leverage

Current Ratio

3.21

Quick Ratio

2.75

Debt / Equity

0.66

Total Cash

838.75M

Total Debt

347.75M

About

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.